Role of scintigraphy with 99mTc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 8, 2012, Pages 1339-1347

  Conti, F ^a   Malviya, G ^b,c   Ceccarelli, F ^a   Priori, R ^a   Iagnocco, A ^a   Valesini, G ^a   Signore, A ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anti TNFa monoclonal antibody; Infliximab; Molecular imaging; Rheumatoid arthritis; Therapy decision making

Indexed keywords

HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; SALAZOSULFAPYRIDINE; TECHNETIUM 99M; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; TECHNETIUM COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANKLE ARTHRITIS; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; FEMALE; HUMAN; KNEE ARTHRITIS; MALE; MONARTHRITIS; PREDICTOR VARIABLE; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYSTEMIC THERAPY; TREATMENT RESPONSE; ARTHRITIS; DECISION MAKING; DRUG ANTAGONISM; DRUG RESISTANCE; ECHOGRAPHY; JOINT; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS; ARTHRITIS, RHEUMATOID; DECISION MAKING; DRUG RESISTANCE; FEMALE; HUMANS; JOINTS; MALE; ORGANOTECHNETIUM COMPOUNDS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865475485     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2133-9     Document Type: Article

References (25)

1. Scott DL, Kingsley GH. Tumour necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med. 2006;355:704-12.
2. DeleuranBW, Chu CQ, Field M, Brennan FM, Mitchell T, Feldmann M, et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum. 1992;35:1170-8.
3. Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med. 2004;350:2167-79.
4. Bokarewa M, Tarkowski A. Local infusion ofinfliximab for the treatment of acute joint inflammation. Ann Rheum Dis. 2003;62:783-4. (Pubitemid 36886419)
5. Nikas SN, Temekonidis TI, Zikou AK, ArgyropoulouMI, Efremidis S, Drosos AA. Treatment of resistant rheumatoid arthritis by intraarticular infliximab injections: a pilot study. Ann Rheum Dis. 2004;63:102-3. (Pubitemid 38064614)
6. Schatteman L, Gyselbrecht L, De Clercq L, Mielants H. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection ofinfliximab. J Rheumatol. 2006;33:82-5. (Pubitemid 43054285)
7. Conti F, Priori R, Chimenti MS, Coari G, Annovazzi A, Valesini G, et al. Successful treatment with intraarticular infliximab for resistant knee monoarthritis in a patient with spondyloarthropathy. A role for scintigraphy with 99mTc-infliximab. Arthritis Rheum. 2005;52:1224-46.
8. Alstergren P, Larsson PT, Kopp S. Successful treatment with multiple intra-articular injections ofinfliximab in a patient with psoriatic arthritis. Scand J Rheumatol. 2008;37(2):155-7. (Pubitemid 351536079)
9. Bliddal H, Terslev L,Qvistgaard E, Recke P, Holm CC, Danneskiold-Samsoe B, et al. Safety ofintra-articular injection of etanercept in small-joint arthritis: an uncontrolled, pilot-study with independent imaging assessment. Joint Bone Spine. 2006;73(6):714-7. (Pubitemid 44918421)
10. Boesen M, Boesen L, Jensen KE, Cimmino MA, Torp-Pedersen S, Terslev L, et al. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks. J Rheumatol. 2008;35(4):584-91. (Pubitemid 351506353)
11. Conti F, Ceccarelli F, Priori R, Iagnocco A, Signore A, Valesini G. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha. Ann Rheum Dis. 2008;67(12):1787-90.
12. Haroon M, O'Gradaigh D. Efficacy and safety of combining intraarticular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory monoarthritis. Joint Bone Spine. 2010;77(3):232-4.
13. Fioravanti A, Fabbroni M, Cerase A, Galeazzi M. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol Int. 2009;29(8):961-5.
14. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001;60(7):641-9. (Pubitemid 32588366)
15. Fiocco U, Sfriso P, Oliviero F, Roux-Lombard P, Scagliori E, Cozzi L, et al. Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. Arthritis Res Ther. 2010;12(4):R148.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24. (Pubitemid 18091653)
17. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218-27.
18. D'Alessandria C, Malviya G, Viscido A, Aratari A, Maccioni F, Amato A, et al. Use of a 99mTc labeled anti-TNFalpha monoclonal antibody in Crohn's disease: in vitro and in vivo studies. Q J Nucl Med Mol Imaging. 2007;51:1-9.
19. Chapman PT, Jamar F, Keelan ET, Peters AM, Haskard DO. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum. 1996;39:1371-5. (Pubitemid 26270097)
20. Jamar F, Chapman PT, Manicourt DH, Glass DM, Haskard DO, Peters AM. A comparison between 111In-anti-E-selectin mAb and 99mTc-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Br J Radiol. 1997;70:473-81. (Pubitemid 27229267)
21. Lopes FP, de Azevedo MN, Marchiori E, da Fonseca LM, de Souza SA, Gutfilen B. Use of 99mTc-anti-CD3 scintigraphy in the differential diagnosis of rheumatic diseases. Rheumatology. 2010;49:933-9.
22. van der Lubbe PA, Arndt JW, Calame W, Ferreira TC, Pauwels EK, Breedveld FC. Measurement of synovial inflammation in rheumatoid arthritis with technetium-99m labelled human polyclonal immunoglobulin G. Eur J Nucl Med. 1991;18:119-23.
23. de Bois MH, Arndt JW, van der Velde EA, van der Lubbe PA, Westedt ML, Pauwels EK, et al. 99mTc human immunoglobulin scintigraphy -a reliable method to detect joint activity in rheumatoid arthritis. J Rheumatol. 1992;19:1371-6.
24. Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA. Molecular imaging ofinflammation/infection: nuclear medicine and optical imaging agents and methods. Chem Rev. 2010;110 (5):3112-45.
25. Malviya G, Galli F, Sonni I, Pacilio M, Signore A. Targeting T and B lymphocytes with radiolabelled antibodies for diagnostic and therapeutic applications. Q J Nucl Med Mol Imaging. 2010;54 (6):654-76.